Eating Disorders News and Research

Latest Eating Disorders News and Research

Study challenges notion of fear of weight gain in patients with anorexia nervosa

A study from Inserm, Paris Descartes University and Sainte Anne Hospital suggests that anorexia nervosa might not be explained by fear of gaining weight, but by the pleasure of losing it... and that the phenomenon might be genetically influenced.

8 Jun 2016

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

2 Jun 2016

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

A child feels nauseated all the time, but no medical test can find what is wrong. Or a child vomits regularly, but there's no illness or eating disorder to explain it. These, and other stomach and bowel-related problems with no obvious causes, are called functional gastrointestinal disorders.

1 Jun 2016

Researchers explore link between social media, eating disorders, and compulsive exercise

In a new open access article for Cogent Social Sciences; Mobile Exercising and Tweeting the Pounds Away: The Use of Digital Applications and Microblogging and their Association with Disordered Eating and Compulsive Exercise, researchers from Georgia College & State University, and Chapman University explore the relationship between social media, eating disorders, and compulsive exercise.

23 May 2016

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

23 May 2016

Women suffering from anorexia nervosa or obesity may respond differently to taste

Researchers at the University of Colorado Anschutz Medical Campus have discovered that women suffering from anorexia nervosa and those who are obese respond differently to taste, a finding that could lead to new treatments for the eating disorders.

17 May 2016

Transcranial direct current stimulation proves effective for binge-eating disorder

Transcranial direct current stimulation, or tDCS, has proved effective for binge-eating disorder for the first time, according to researchers at the University of Alabama at Birmingham.

10 May 2016

Bayer-new phase 3 liver cancer data

Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.

4 May 2016

Combination of genetic, environmental risk factors can trigger fatal eating disorder in humans

In a new study, researchers from Columbia University Medical Center described a new mouse model featuring a combination of genetic and environmental risk factors that can trigger the compulsive restriction of food intake seen in patients with anorexia nervosa. The findings may help to identify new prevention and treatment strategies for the eating disorder in humans.

12 Apr 2016

Radiation therapy plus PCV chemotherapy improves survival of low-grade glioma patients

Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than patients who received radiation therapy alone, according to the results of the clinical trial, Radiation Therapy Oncology Group 9802 published in the April 7 issue of the New England Journal of Medicine.

7 Apr 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

16 Feb 2016

Mortality risk higher in people with eating disorders

Results from a newly published study indicate that individuals with eating disorders are at increased risk of death compared to the general population. Investigators found that individuals with anorexia nervosa (AN) had a five times higher mortality rate than their same age peers.

22 Jan 2016

Psychological techniques help reduce body dissatisfaction in women with bulimia nervosa

Researchers from the University of Granada have proven that there are two psychological techniques that help reducing body dissatisfaction and its associated symptoms in women with bulimia nervosa, both of them based in the exposure of their bodies in a mirror.

21 Jan 2016

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today emphasizes the continued availability of Daraprim and cautions healthcare providers of proposed alternatives to Daraprim.

20 Dec 2015

Holidays can be a tough time for people with eating disorders

With food everywhere you look, difficult relatives and pressure to create perfect memories, the holidays can be a tough time for those who struggle with eating disorders.

13 Dec 2015

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Scientists at Oregon Research Institute have published unique research results indicating that a brief dissonance-based eating disorder prevention program (Body Project) alters how young women's brains respond to images of thin supermodels.

9 Dec 2015

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency accepted for review, the marketing authorization application (MAA) for anamorelin HCI, a novel, orally active selective ghrelin receptor agonist under development for the treatment of anorexia, cachexia, or unintended weight loss in non-small cell lung cancer (NSCLC) patients.

30 Nov 2015

Bullies and victims at risk for eating disorders

Being bullied in childhood has been associated with increased risk for anxiety, depression and even eating disorders. But according to new research, it's not only the victims who could be at risk psychologically, but also the bullies themselves.

17 Nov 2015

Research findings open up new avenues for treatment of people with anorexia nervosa

When people with anorexia nervosa decide what to eat, they engage a part of the brain associated with habitual behavior. This finding by researchers at Columbia University Medical Center, New York State Psychiatric Institute, the Mortimer B. Zuckerman Mind Brain Behavior Institute, and New York University was published today in Nature Neuroscience.

13 Oct 2015

Eating Disorders News and Research

Latest Eating Disorders News and Research

Study challenges notion of fear of weight gain in patients with anorexia nervosa

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

Researchers explore link between social media, eating disorders, and compulsive exercise

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Women suffering from anorexia nervosa or obesity may respond differently to taste

Transcranial direct current stimulation proves effective for binge-eating disorder

Bayer-new phase 3 liver cancer data

Combination of genetic, environmental risk factors can trigger fatal eating disorder in humans

Radiation therapy plus PCV chemotherapy improves survival of low-grade glioma patients

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Mortality risk higher in people with eating disorders

Psychological techniques help reduce body dissatisfaction in women with bulimia nervosa

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Holidays can be a tough time for people with eating disorders

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

Bullies and victims at risk for eating disorders

Research findings open up new avenues for treatment of people with anorexia nervosa

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eating Disorders News and Research

Latest Eating Disorders News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in